279 related articles for article (PubMed ID: 32883160)
21. Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
Ernest JM; Marshburn PB; Kutteh WH
Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465
[TBL] [Abstract][Full Text] [Related]
22. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
Cervera R; Tektonidou MG; Espinosa G; Cabral AR; González EB; Erkan D; Vadya S; Adrogué HE; Solomon M; Zandman-Goddard G; Shoenfeld Y
Lupus; 2011 Feb; 20(2):165-73. PubMed ID: 21303833
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid Syndrome Clinical Research Task Force report.
Erkan D; Derksen R; Levy R; Machin S; Ortel T; Pierangeli S; Roubey R; Lockshin M
Lupus; 2011 Feb; 20(2):219-24. PubMed ID: 21303838
[TBL] [Abstract][Full Text] [Related]
24. The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.
Abreu MM; Danowski A; Wahl DG; Amigo MC; Tektonidou M; Pacheco MS; Fleming N; Domingues V; Sciascia S; Lyra JO; Petri M; Khamashta M; Levy RA
Autoimmun Rev; 2015 May; 14(5):401-14. PubMed ID: 25641203
[TBL] [Abstract][Full Text] [Related]
25. Current management of antiphospholipid syndrome-related thrombosis.
Puente D; Pombo G; Forastiero R
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
[TBL] [Abstract][Full Text] [Related]
26. 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome.
Sciascia S; Radin M; Cecchi I; Levy RA; Erkan D
Lupus; 2021 Jul; 30(8):1314-1326. PubMed ID: 34039107
[TBL] [Abstract][Full Text] [Related]
27. Obstetric anti-phospholipid syndrome: from pathogenesis to treatment.
Kaneko K; Ozawa N; Murashima A
Immunol Med; 2022 Jun; 45(2):79-93. PubMed ID: 34470570
[TBL] [Abstract][Full Text] [Related]
28. Obstetric and vascular APS: same autoantibodies but different diseases?
Meroni PL; Raschi E; Grossi C; Pregnolato F; Trespidi L; Acaia B; Borghi MO
Lupus; 2012 Jun; 21(7):708-10. PubMed ID: 22635208
[TBL] [Abstract][Full Text] [Related]
29. Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome.
Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Zhou Z; Jia J; Wang Z; Zhou J; Norman GL; Wang X; Yang C; Shi H
Thromb Res; 2020 Jan; 185():142-149. PubMed ID: 31816554
[TBL] [Abstract][Full Text] [Related]
30. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
[TBL] [Abstract][Full Text] [Related]
31. [Clinical features and treatments of antiphospholipid syndrome].
Kaburaki J
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Jun; 31(3):152-8. PubMed ID: 18587225
[TBL] [Abstract][Full Text] [Related]
32. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.
Lefèvre G; Lambert M; Bacri JL; Dubucquoi S; Quemeneur T; Caron C; Launay D; Houfflin-Debarge V; Hachulla E; Kyndt X; Subtil D; Hatron PY
Lupus; 2011 Jul; 20(8):861-5. PubMed ID: 21546412
[TBL] [Abstract][Full Text] [Related]
33. Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?
De Carolis S; Botta A; Salvi S; di Pasquo E; Del Sordo G; Garufi C; Lanzone A; De Carolis MP
Autoimmun Rev; 2015 Sep; 14(9):760-2. PubMed ID: 25936295
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
35. The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.
Willis R; Gonzalez EB; Brasier AR
Curr Rheumatol Rep; 2015 Mar; 17(3):16. PubMed ID: 25761923
[TBL] [Abstract][Full Text] [Related]
36. Top 10 clinical research developments in antiphospholipid syndrome.
Barbhaiya M; Erkan D
Curr Rheumatol Rep; 2013 Oct; 15(10):367. PubMed ID: 24014256
[TBL] [Abstract][Full Text] [Related]
37. The antiphospholipid syndrome.
Wautrecht JC
Acta Neurol Belg; 2002 Dec; 102(4):158-62. PubMed ID: 12534241
[TBL] [Abstract][Full Text] [Related]
38. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
[TBL] [Abstract][Full Text] [Related]
40. Obstetric antiphospholipid syndrome.
Galarza-Maldonado C; Kourilovitch MR; Pérez-Fernández OM; Gaybor M; Cordero C; Cabrera S; Soroka NF
Autoimmun Rev; 2012 Feb; 11(4):288-95. PubMed ID: 22001418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
